These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 307036)
1. [Correlation between blood CEA and T cells in patients having carcinoma in the digestive organs (author's transl)]. Naruki Y; Mugitani H; Ohtsuka S; Shimbo T; Yata J Nihon Gan Chiryo Gakkai Shi; 1978 Apr; 13(2):107-17. PubMed ID: 307036 [No Abstract] [Full Text] [Related]
2. [Changes of T cells in the course of the treatment of malignant tumors of the digestive organs (author's transl)]. Mugitani H; Naruki Y; Ohtsuka S; Shinbo T; Yata J Nihon Gan Chiryo Gakkai Shi; 1978 Feb; 13(1):12-9. PubMed ID: 307035 [No Abstract] [Full Text] [Related]
3. [The clinical value of the plasma CEA level for postoperative detection of recurrence and metastases of carcinoma of the gastrointestinal tract (author's transl)]. Auer IL; Schmid L; Hoecht B; Kaufner G; Leclerq R Med Klin; 1977 May; 72(21):934-41. PubMed ID: 875869 [No Abstract] [Full Text] [Related]
4. [Study on the clinical application of plasma and tissue carcinoembryonic antigen to cases with bile duct carcinoma]. Fukuda Y Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):324-35. PubMed ID: 3713684 [TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. Holyoke D; Reynoso G; Chu TM Ann Surg; 1972 Oct; 176(4):559-64. PubMed ID: 5077412 [No Abstract] [Full Text] [Related]
6. [Radioimmunoassay of carcinoembryogenic antigen (CEA) in patients with carcinoma. Conclusion from preliminary results of a collaborative study in Switzerland]. Mach JP; Pusztaszeri G; Dysli M; Kapp F; Bierens de Haan B; Loosli RM; Grob P; Isliker H Schweiz Med Wochenschr; 1973 Mar; 103(10):365-71. PubMed ID: 4120789 [No Abstract] [Full Text] [Related]
8. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract]. Tappero G; Piantino P; Cerchier A; Pecchio F Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313 [TBL] [Abstract][Full Text] [Related]
9. [Carcinoembryonic antigen (CEA) in the digestive diseases (author's transl)]. Bekhti A; Collette J; Franchimont P Arch Fr Mal App Dig; 1975; 64(5):399-406. PubMed ID: 1212060 [No Abstract] [Full Text] [Related]
10. [Prognostic value of circulating immune complexes of carcinoembryonic antigen (CEA) in patients with adenocarcinoma of the gastrointestinal tract (author's transl)]. Staab HJ; Anderer FA; Stumpf E; Fischer R J Clin Chem Clin Biochem; 1980 Mar; 18(3):175-81. PubMed ID: 7381371 [TBL] [Abstract][Full Text] [Related]
11. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract. Harmenberg U; Wahren B; Wiechel KL Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472 [TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases. Zamcheck N Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719 [No Abstract] [Full Text] [Related]
13. [Studies on cellular immunity in cancer of the digestive organs (author's transl)]. Mugitani H; Ohtsuka S; Shinbo T; Yata J Nihon Shokakibyo Gakkai Zasshi; 1979 Jun; 76(6):1337-49. PubMed ID: 314009 [No Abstract] [Full Text] [Related]
14. [Quantitative determination of carcinoembryonic antigen (CEA) in tumors of the digestive tract]. Richart C; Ruibal A; Monne J; Guardia J Rev Esp Enferm Apar Dig; 1979 Jan; 55(1):23-30. PubMed ID: 441493 [No Abstract] [Full Text] [Related]
15. [Value of the determination of carcinoembryonic antigen (CEA) in benign and tumoral digestive pathology, chronic hepathopathies and hepatomas: study of 190 cases]. Escudero Navarro JM; Rodrigo Saez L; Morcillo Herrera L; Faedo Presa I; Cornago Sánchez A; Pérez Alvarez R; García Saavedra L Rev Esp Enferm Apar Dig; 1980 Sep; 58(3):267-74. PubMed ID: 6256829 [No Abstract] [Full Text] [Related]
16. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP]. Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133 [TBL] [Abstract][Full Text] [Related]
17. [Carcinoembryonic antigen (CEA). Clinical significance of postoperative concentration change of CEA in serums of patients with carcinoma of the stomach and intestinal tract]. Staab HJ; Kapsopoulou K; Anderer FA; Stumpt E; Fischer R Med Welt; 1976 Apr; 27(18):864-7. PubMed ID: 1272048 [No Abstract] [Full Text] [Related]
18. Correlation of carcinoembryonic antigen content with carboxylesterase activity in benign and malignant human tissues. Munjal D; Zamcheck N; Kupchik HZ; Saravis CA Cancer Res; 1974 Nov; 34(11):2936-9. PubMed ID: 4419619 [No Abstract] [Full Text] [Related]
19. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases]. Czakó L; Takács T; Babarczy E; Dux L; Lonovics J Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study of carcino-embryonic antigen and beta2-microglobulin. Methodological study and clinical interpretation (author's transl)]. Depierre A; Kadouche J; Chamagne AM; Najean Y Pathol Biol (Paris); 1978 Sep; 26(6):341-2. PubMed ID: 83578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]